HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with PharmaJet® to evaluate the safety and immunogenicity of HIV therapeutic DNA vaccine,...
Hence then, the article about immuno cure and pharmajet announce collaboration to advance a novel hiv therapeutic dna vaccine using needle free technology in humans was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans )
Also on site :
- Governor Hochul: Annual statewide donation drive is complete
- Tornado warning issued, and quickly cancelled, over Alhambra
- Skier dies in collision with tree at Colorado’s Aspen Mountain, resort officials confirm